{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:19:50Z","timestamp":1791667190957,"version":"4.3.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"dana impak perdana","award":["DIP-2019-007"],"award-info":[{"award-number":["DIP-2019-007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00415-021-10874-2","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T17:02:48Z","timestamp":1636218168000},"page":"2315-2337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Pharmacological and non-pharmacological management of spinocerebellar ataxia: A systematic review"],"prefix":"10.1007","volume":"269","author":[{"given":"Kah Hui","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrul","family":"Azmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemaima","family":"Che Hamzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norfazilah","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van de Warrenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6684-7488","authenticated-orcid":false,"given":"Norlinah","family":"Mohamed Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,6]]},"reference":[{"key":"10874_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12311-015-0687-3","volume":"15","author":"F Bodranghien","year":"2016","unstructured":"Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, Mari\u00ebn P, Nowak DA, Schmahmann JD, Serrao M (2016) Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum 15:369\u2013391","journal-title":"Cerebellum"},{"key":"10874_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42:174\u2013183","journal-title":"Neuroepidemiology"},{"key":"10874_CR3","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","volume":"14","author":"H Jacobi","year":"2015","unstructured":"Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P (2015) Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol 14:1101\u20131108","journal-title":"Lancet Neurol"},{"key":"10874_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/mds.20533","volume":"20","author":"M Maschke","year":"2005","unstructured":"Maschke M, Oehlert G, Xie TD, Perlman S, Subramony SH, Kumar N, Ptacek LJ, Gomez CM (2005) Clinical feature profile of spinocerebellar ataxia type 1\u20138 predicts genetically defined subtypes. Mov Disord 20:1405\u20131412","journal-title":"Mov Disord"},{"key":"10874_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mds.21798","volume":"23","author":"J L\u00f3pez-Bastida","year":"2008","unstructured":"L\u00f3pez-Bastida J, Perestelo-P\u00e9rez L, Mont\u00f3n-\u00e1lvarez F, Serrano-Aguilar P (2008) Social economic costs and health-related quality of life in patients with degenerative cerebellar ataxia in Spain. Mov Disord 23:212\u2013217","journal-title":"Mov Disord"},{"key":"10874_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1474-4422(18)30042-5","volume":"17","author":"A Diallo","year":"2018","unstructured":"Diallo A, Jacobi H, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L (2018) Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study. Lancet Neurol 17:327\u2013334","journal-title":"Lancet Neurol"},{"key":"10874_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40673-019-0107-4","volume":"6","author":"C Bolton","year":"2019","unstructured":"Bolton C, Lacy M (2019) Comparison of cognitive profiles in spinocerebellar ataxia subtypes: a case series. Cerebellum Ataxias 6:13\u201316","journal-title":"Cerebellum Ataxias"},{"key":"10874_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL (2019) Spinocerebellar ataxia. Nat Rev Dis Primers 5:24","journal-title":"Nat Rev Dis Primers"},{"key":"10874_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cortex.2009.11.008","volume":"46","author":"CJ Stoodley","year":"2010","unstructured":"Stoodley CJ, Schmahmann JD (2010) Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex 46:831\u2013844","journal-title":"Cortex"},{"key":"10874_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnsys.2013.00083","volume":"7","author":"SL Reeber","year":"2013","unstructured":"Reeber SL, Otis TS, Sillitoe RV (2013) New roles for the cerebellum in health and disease. Front Syst Neurosci 7:1\u201311","journal-title":"Front Syst Neurosci"},{"key":"10874_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12311-011-0318-6","volume":"11","author":"P Braga-Neto","year":"2012","unstructured":"Braga-Neto P, Pedroso JL, Alessi H, Dutra LA, Fel\u00edcio AC, Minett T, Weisman P, Santos-Galduroz RF, Bertolucci PHF, Gabbai AA (2012) Cerebellar cognitive affective syndrome in Machado Joseph disease: Core clinical features. Cerebellum 11:549\u2013556","journal-title":"Cerebellum"},{"key":"10874_CR12","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.12688\/f1000research.15788.1","volume":"7","author":"G Coarelli","year":"2018","unstructured":"Coarelli G, Brice A, Durr A (2018) Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view. F1000Research 7:1781\u20131790","journal-title":"F1000Research"},{"key":"10874_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","volume":"14","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa T, \u00d6z G, Paulson HL (2018) Spinocerebellar ataxias: prospects and challenges for therapy development. Nat Rev Neurol 14:590\u2013605","journal-title":"Nat Rev Neurol"},{"key":"10874_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/mdc3.12057","volume":"1","author":"H Sarva","year":"2014","unstructured":"Sarva H, Shanker VL (2014) Treatment options in degenerative cerebellar ataxia: a systematic review. Mov Disord Clin Pract 1:291\u2013298","journal-title":"Mov Disord Clin Pract"},{"key":"10874_CR15","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"M Page","year":"2021","unstructured":"Page M, McKenzie JB, Boutron PMI, Hoffmann T, Mulrow CS, Tetzlaff JL, Akl E, Brennan S, Chou R, Glanville J, Grimshaw J, Hr\u00f3bjartsson A, Lalu M, Li T, Loder E, Mayo-Wilson E, McDonald SM, Stewart LAL, Thomas J, Tricco A, Welch V, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"10874_CR16","doi-asserted-by":"crossref","unstructured":"Higgins JP, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JA (2019) Assessing risk of bias in a randomized trial. In: Cochrane Handbook for Systematic Reviews of Interventions, pp 205\u201328","DOI":"10.1002\/9781119536604.ch8"},{"key":"10874_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1468-1331.2004.00867.x","volume":"11","author":"M Brainin","year":"2004","unstructured":"Brainin M, Barnes M, Baron JC, Gilhus N, Hughes R, Selmaj K, Waldemar G (2004) Guidance for the preparation of neurological management guidelines by EFNS scientific task forces\u2013revised recommendations 2004. Eur J Neurol 11:577\u2013581","journal-title":"Eur J Neurol"},{"key":"10874_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1600-0404.2005.00405.x","volume":"111","author":"CS Liu","year":"2005","unstructured":"Liu CS, Hsu HM, Cheng WL, Hsieh M (2005) Clinical and molecular events in patients with Machado-Joseph disease under lamotrigine therapy. Acta Neurol Scand 111:385\u2013390","journal-title":"Acta Neurol Scand"},{"key":"10874_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF01276511","volume":"102","author":"T Sakai","year":"1995","unstructured":"Sakai T, Matsuishi T, Yamada S, Komori H, Iwashita H (1995) Sulfamethoxazole-trimethoprim double-blind, placebo-controlled, crossover trial in Machado-Joseph disease: Sulfamethoxazole-trimethoprim increases cerebrospinal fluid level of biopterin. J Neural Transm\/Gen Sect 102:159\u2013172","journal-title":"J Neural Transm\/Gen Sect"},{"key":"10874_CR20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/archneur.58.9.1451","volume":"58","author":"T Schulte","year":"2001","unstructured":"Schulte T, Mattern R, Berger K, Szymanski S, Klotz P, Kraus PH, Przuntek H, Sch\u00f6ls L (2001) Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3\/Machado-Joseph disease. Arch Neurol 58:1451\u20131457","journal-title":"Arch Neurol"},{"key":"10874_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0022-510X(95)00296-E","volume":"136","author":"T Sakai","year":"1996","unstructured":"Sakai T, Antoku Y, Matsuishi T, Iwashita H (1996) Tetrahydrobiopterin double-blind, crossover trial in Machado-Joseph disease. J Neurol Sci 136:71\u201372","journal-title":"J Neurol Sci"},{"key":"10874_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/archneur.1997.00550160041013","volume":"54","author":"K Wessel","year":"1997","unstructured":"Wessel K, Langenberger K, Nitschke MF, K\u00f6mpf D (1997) Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases. Arch Neurol 54:397\u2013400","journal-title":"Arch Neurol"},{"key":"10874_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/462182","volume":"2015","author":"Y-Z Huang","year":"2015","unstructured":"Huang Y-Z, Chang Y-S, Hsu M-J, Wong AM, Chang Y-J (2015) Restoration of central programmed movement pattern by temporal electrical stimulation-assisted training in patients with spinal cerebellar atrophy. Neural Plast 2015:1\u20139","journal-title":"Neural Plast"},{"key":"10874_CR24","doi-asserted-by":"crossref","unstructured":"Hong JS, Kim JH, Yong SY, Lee YH, Kim SH, Park JY, Lee JK, Jang JY (2020) Preliminary clinical trial of balance compensation system for improvement of balance in patients with spinocerebellar ataxia. J Korean Acad Rehabil Med","DOI":"10.5535\/arm.19165"},{"key":"10874_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12984-018-0425-4","volume":"15","author":"A Tsukahara","year":"2018","unstructured":"Tsukahara A, Yoshida K, Matsushima A, Ajima K, Kuroda C, Mizukami N, Hashimoto M (2018) Effects of gait support in patients with spinocerebellar degeneration by a wearable robot based on synchronization control. J Neuroeng Rehabil 15:84","journal-title":"J Neuroeng Rehabil"},{"key":"10874_CR26","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","volume":"14","author":"S Romano","year":"2015","unstructured":"Romano S, Coarelli G, Marcotulli C, Leonardi L, Piccolo F, Spadaro M, Frontali M, Ferraldeschi M, Vulpiani MC, Ponzelli F (2015) Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 14:985\u2013991","journal-title":"Lancet Neurol"},{"key":"10874_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/00498254.2017.1423130","volume":"49","author":"K Kobayashi","year":"2019","unstructured":"Kobayashi K, Abe Y, Harada H, Oota E, Endo T, Takeda H (2019) Non-Clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue. Xenobiotica 49:106\u2013119","journal-title":"Xenobiotica"},{"key":"10874_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/mds.25803","volume":"29","author":"JAM Saute","year":"2014","unstructured":"Saute JAM, de Castilhos RM, Monte TL, Schumacher-Schuh AF, Donis KC, D\u2019\u00c1vila R, Souza GN, Russo AD, Furtado GV, Gheno TC (2014) A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease. Mov Disord 29:568\u2013573","journal-title":"Mov Disord"},{"key":"10874_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.parkreldis.2016.03.005","volume":"26","author":"L-F Lei","year":"2016","unstructured":"Lei L-F, Yang G-P, Wang J-L, Chuang D-M, Song W-H, Tang B-S, Jiang H (2016) Safety and efficacy of valproic acid treatment in SCA3\/MJD patients. Parkinsonism Relat Disord 26:55\u201361","journal-title":"Parkinsonism Relat Disord"},{"key":"10874_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1212\/WNL.0b013e318247cc7a","volume":"78","author":"TA Zesiewicz","year":"2012","unstructured":"Zesiewicz TA, Greenstein P, Sullivan KL, Wecker L, Miller A, Jahan I, Chen R, Perlman S (2012) A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology 78:545\u2013550","journal-title":"Neurology"},{"key":"10874_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0022-510X(02)00009-6","volume":"195","author":"M Mori","year":"2002","unstructured":"Mori M, Adachi Y, Mori N, Kurihara S, Kashiwaya Y, Kusumi M, Takeshima T, Nakashima K (2002) Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration. J Neurol Sci 195:149\u2013152","journal-title":"J Neurol Sci"},{"key":"10874_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s12311-020-01150-6","volume":"19","author":"R Zaltzman","year":"2020","unstructured":"Zaltzman R, Elyoseph Z, Lev N, Gordon CR (2020) Trehalose in Machado-Joseph disease: safety, tolerability, and efficacy. Cerebellum 19:672\u2013679","journal-title":"Cerebellum"},{"key":"10874_CR33","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s11064-011-0496-0","volume":"36","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2011","unstructured":"Vel\u00e1zquez-P\u00e9rez L, Rodr\u00edguez-Chanfrau J, Garc\u00eda-Rodr\u00edguez JC, S\u00e1nchez-Cruz G, Aguilera-Rodr\u00edguez R, Rodr\u00edguez-Labrada R, Rodr\u00edguez-D\u00edaz JC, Canales-Ochoa N, Gotay DA, Mederos LEA (2011) Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial. Neurochem Res 36:1793\u20131800","journal-title":"Neurochem Res"},{"key":"10874_CR34","first-page":"12","volume":"13","author":"C Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez C, S\u00e1nchez G, Gonz\u00e1lez Quevedo A, Delgado R, Vel\u00e1zquez L, Garc\u00eda RJ (2005) Serum and cerebrospinal fluid levels of copper, iron and zinc in patiens with Ataxia type SCA-2 from the province of Holguin in Cuba. Ther Basic Dialogues Clin Neurosci 13:12\u201316","journal-title":"Ther Basic Dialogues Clin Neurosci"},{"key":"10874_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00415-003-1061-9","volume":"250","author":"JC Bier","year":"2003","unstructured":"Bier JC, Dethy S, Hildebrand J, Jacquy J, Manto M, Martin J-J, Seeldrayers P (2003) Effects of the oral form of ondansetron on cerebellar dysfunction. J Neurol 250:693\u2013697","journal-title":"J Neurol"},{"key":"10874_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1034\/j.1600-0404.2001.00299.x","volume":"104","author":"I Yabe","year":"2001","unstructured":"Yabe I, Sasaki H, Yamashita I, Takei A, Tashiro K (2001) Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry. Acta Neurol Scand 104:44\u201347","journal-title":"Acta Neurol Scand"},{"key":"10874_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00002826-200401000-00005","volume":"27","author":"A Takei","year":"2004","unstructured":"Takei A, Fukazawa T, Hamada T, Sohma H, Yabe I, Sasaki H, Tashiro K (2004) Effects of tandospirone on \u201c5-HT1A receptor-associated symptoms\u201d in patients with Machado-Josephe disease: an open-label study. Clin Neuropharmacol 27:9\u201313","journal-title":"Clin Neuropharmacol"},{"key":"10874_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12311-010-0199-0","volume":"9","author":"A Takei","year":"2010","unstructured":"Takei A, Hamada S, Homma S, Hamada K, Tashiro K, Hamada T (2010) Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study. Cerebellum 9:567\u2013570","journal-title":"Cerebellum"},{"key":"10874_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.parkreldis.2019.12.007","volume":"70","author":"M Noorasyikin","year":"2020","unstructured":"Noorasyikin M, Elena A, Teh P, Waheeda TF, Hajar MS, Long K, Norlinah M (2020) Oral trehalose maybe helpful for patients with spinocerebellar ataxia 3 and should be better evaluated. Parkinsonism Relat Disord 70:42\u201344","journal-title":"Parkinsonism Relat Disord"},{"key":"10874_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/0366-6999.150087","volume":"128","author":"S Tan","year":"2015","unstructured":"Tan S, Wang R-H, Niu H-X, Shi C-H, Mao C-Y, Zhang R, Song B, Sun S-L, Liu X-J, Hou H-M (2015) Nerve growth factor for the treatment of spinocerebellar ataxia type 3: An open-label study. Chin Med J 128:291\u2013294","journal-title":"Chin Med J"},{"key":"10874_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/156720213804805936","volume":"10","author":"J-L Jin","year":"2013","unstructured":"Jin J-L, Liu Z, Lu Z-J, Guan D-N, Wang C, Chen Z-B, Zhang J, Zhang W-Y, Wu J-Y, Xu Y (2013) Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia. Curr Neurovasc Res 10:11\u201320","journal-title":"Curr Neurovasc Res"},{"key":"10874_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3727\/096368916X694373","volume":"26","author":"Y-A Tsai","year":"2017","unstructured":"Tsai Y-A, Liu R-S, Lirng J-F, Yang B-H, Chang C-H, Wang Y-C, Wu Y-S, Ho JH-C, Lee OK, Soong B-W (2017) Treatment of spinocerebellar ataxia with mesenchymal stem cells: a phase I\/IIa clinical study. Cell Transpl 26:503\u2013512","journal-title":"Cell Transpl"},{"key":"10874_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1177\/1545968311425918","volume":"26","author":"I Miyai","year":"2012","unstructured":"Miyai I, Ito M, Hattori N, Mihara M, Hatakenaka M, Yagura H, Sobue G, Nishizawa M (2012) Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases. Neurorehabil Neural Repair 26:515\u2013522","journal-title":"Neurorehabil Neural Repair"},{"key":"10874_CR44","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/mds.27437","volume":"33","author":"JC Rodr\u00edguez-D\u00edaz","year":"2018","unstructured":"Rodr\u00edguez-D\u00edaz JC, Vel\u00e1zquez-P\u00e9rez L, Rodr\u00edguez Labrada R, Aguilera Rodr\u00edguez R, Laffita P\u00e9rez D, Canales Ochoa N, Medrano Montero J, Estupi\u00f1\u00e1n Rodr\u00edguez A, Osorio Borjas M, G\u00f3ngora MM (2018) Neurorehabilitation therapy in spinocerebellar ataxia type 2: a 24-week, rater-blinded, randomized, controlled trial. Mov Disord 33:1481\u20131487","journal-title":"Mov Disord"},{"key":"10874_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12311-019-1006-1","volume":"18","author":"K Tercero-P\u00e9rez","year":"2019","unstructured":"Tercero-P\u00e9rez K, Cort\u00e9s H, Torres-Ramos Y, Rodr\u00edguez-Labrada R, Cerecedo-Zapata CM, Hern\u00e1ndez-Hern\u00e1ndez O, P\u00e9rez-Gonz\u00e1lez N, Gonz\u00e1lez-Pi\u00f1a R, Leyva-Garc\u00eda N, Cisneros B (2019) Effects of physical rehabilitation in patients with spinocerebellar ataxia type 7. Cerebellum 18:397\u2013405","journal-title":"Cerebellum"},{"key":"10874_CR46","first-page":"1","volume":"8","author":"R-Y Wang","year":"2018","unstructured":"Wang R-Y, Huang F-Y, Soong B-W, Huang S-F, Yang Y-R (2018) A randomized controlled pilot trial of game-based training in individuals with spinocerebellar ataxia type 3. Sci Rep 8:1\u20137","journal-title":"Sci Rep"},{"key":"10874_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0269215514539336","volume":"29","author":"LM Bunn","year":"2015","unstructured":"Bunn LM, Marsden JF, Giunti P, Day BL (2015) Training balance with opto-kinetic stimuli in the home: a randomized controlled feasibility study in people with pure cerebellar disease. Clin Rehabil 29:143\u2013153","journal-title":"Clin Rehabil"},{"key":"10874_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12311-013-0532-5","volume":"13","author":"O Kaut","year":"2014","unstructured":"Kaut O, Jacobi H, Coch C, Prochnicki A, Minnerop M, Klockgether T, W\u00fcllner U (2014) A randomized pilot study of stochastic vibration therapy in spinocerebellar ataxia. Cerebellum 13:237\u2013242","journal-title":"Cerebellum"},{"key":"10874_CR49","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.apmr.2015.01.021","volume":"96","author":"Y-J Chang","year":"2015","unstructured":"Chang Y-J, Chou C-C, Huang W-T, Lu C-S, Wong AM, Hsu M-J (2015) Cycling regimen induces spinal circuitry plasticity and improves leg muscle coordination in individuals with spinocerebellar ataxia. Arch Phys Med Rehabil 96:1006\u20131013","journal-title":"Arch Phys Med Rehabil"},{"key":"10874_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fneur.2019.00073","volume":"10","author":"B Manor","year":"2019","unstructured":"Manor B, Greenstein PE, Davila-Perez P, Wakefield S, Zhou J, Pascual-Leone A (2019) Repetitive transcranial magnetic stimulation in spinocerebellar ataxia: a pilot randomized controlled trial. Front Neurol 10:73","journal-title":"Front Neurol"},{"key":"10874_CR51","doi-asserted-by":"crossref","unstructured":"Fran\u00e7a C, de Andrade DC, Silva V, Galhardoni R, Barbosa ER, Teixeira MJ and Cury RG (2020) Effects of cerebellar transcranial magnetic stimulation on ataxias: a randomized trial. Parkinsonism Relat Disord","DOI":"10.1016\/j.parkreldis.2020.09.001"},{"key":"10874_CR52","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.brs.2016.11.001","volume":"10","author":"A Benussi","year":"2017","unstructured":"Benussi A, Dell\u2019Era V, Cotelli MS, Turla M, Casali C, Padovani A, Borroni B (2017) Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. Brain Stimul 10:242\u2013250","journal-title":"Brain Stimul"},{"key":"10874_CR53","doi-asserted-by":"publisher","first-page":"e1090","DOI":"10.1212\/WNL.0000000000006210","volume":"91","author":"A Benussi","year":"2018","unstructured":"Benussi A, Dell\u2019Era V, Cantoni V, Bonetta E, Grasso R, Manenti R, Cotelli M, Padovani A, Borroni B (2018) Cerebello-spinal tDCS in ataxia: a randomized, double-blind, sham-controlled, crossover trial. Neurology 91:e1090\u2013e1101","journal-title":"Neurology"},{"key":"10874_CR54","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1523\/JNEUROSCI.3381-12.2013","volume":"33","author":"RG Burciu","year":"2013","unstructured":"Burciu RG, Fritsche N, Granert O, Schmitz L, Sp\u00f6nemann N, Konczak J, Theysohn N, Gerwig M, van Eimeren T, Timmann D (2013) Brain changes associated with postural training in patients with cerebellar degeneration: a voxel-based morphometry study. J Neurosci 33:4594\u20134604","journal-title":"J Neurosci"},{"key":"10874_CR55","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1177\/1545968314522350","volume":"28","author":"JL Keller","year":"2014","unstructured":"Keller JL, Bastian AJ (2014) A home balance exercise program improves walking in people with cerebellar ataxia. Neurorehabil Neural Repair 28:770\u2013778","journal-title":"Neurorehabil Neural Repair"},{"key":"10874_CR56","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/21695717.2017.1381490","volume":"15","author":"G Santos","year":"2017","unstructured":"Santos G, Zeigelboim DBS, Severiano M, Teive H, Liberalesso P, Marques J, Cordeiro M (2017) Feasibility of virtual reality-based balance rehabilitation in adults with spinocerebellar ataxia: a prospective observational study. Hear Balance Commun 15:244\u2013251","journal-title":"Hear Balance Commun"},{"key":"10874_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12311-018-0962-1","volume":"18","author":"AM Zimmet","year":"2019","unstructured":"Zimmet AM, Cowan NJ, Bastian AJ (2019) Patients with cerebellar ataxia do not benefit from limb weights. Cerebellum 18:128\u2013136","journal-title":"Cerebellum"},{"key":"10874_CR58","doi-asserted-by":"crossref","unstructured":"Horiuchi M, Maki F, Yanagisawa T, Sugihara H, Takahashi Y, Ohashi K, Sasaka K, Nakajima Y (2002) Therapeutic efficacy of transcranial magnetic stimulation for amyotrophic lateral sclerosis and spinocerebellar degeneration. In: International Congress Series. Elsevier, pp 525\u201332","DOI":"10.1016\/S0531-5131(02)00242-X"},{"key":"10874_CR59","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10072-016-2800-x","volume":"38","author":"L Leonardi","year":"2017","unstructured":"Leonardi L, Aceto MG, Marcotulli C, Arcuria G, Serrao M, Pierelli F, Paone P, Filla A, Roca A, Casali C (2017) A wearable proprioceptive stabilizer for rehabilitation of limb and gait ataxia in hereditary cerebellar ataxias: a pilot open-labeled study. Neurol Sci 38:459\u2013463","journal-title":"Neurol Sci"},{"key":"10874_CR60","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.parkreldis.2015.10.016","volume":"21","author":"MB Nunes","year":"2015","unstructured":"Nunes MB, Martinez ARM, Rezende TJR, Friedman JH, Lopes-Cendes I, D\u2019Abreu A, Fran\u00e7a MC Jr (2015) Dystonia in Machado-Joseph disease: clinical profile, therapy and anatomical basis. Parkinsonism Relat Disord 21:1441\u20131447","journal-title":"Parkinsonism Relat Disord"},{"key":"10874_CR61","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/brain\/awg073","volume":"126","author":"K Kanai","year":"2003","unstructured":"Kanai K, Kuwabara S, Arai K, Sung JY, Ogawara K, Hattori T (2003) Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 126:965\u2013973","journal-title":"Brain"},{"key":"10874_CR62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00415-014-7551-0","volume":"262","author":"F Sacca","year":"2015","unstructured":"Sacca F, Puorro G, Brunetti A, Capasso G, Cervo A, Cocozza S, de Leva M, Marsili A, Pane C, Quarantelli M (2015) A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. J Neurol 262:149\u2013153","journal-title":"J Neurol"},{"key":"10874_CR63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1034\/j.1600-0404.2003.02132.x","volume":"107","author":"TL Monte","year":"2003","unstructured":"Monte TL, Rieder C, Tort A, Rockenback I, Pereira M, Silveira I, Ferro A, Sequeiros J, Jardim LB (2003) Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study. Acta Neurol Scand 107:207\u2013210","journal-title":"Acta Neurol Scand"},{"key":"10874_CR64","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1177\/0269215507076678","volume":"21","author":"S-I Izumi","year":"2007","unstructured":"Izumi S-I, Ando K, Ono M, Suzukamo Y, Michimata A, Fukuhara S (2007) Effect of coaching on psychological adjustment in patients with spinocerebellar degeneration: a pilot study. Clin Rehabil 21:987\u2013996","journal-title":"Clin Rehabil"},{"key":"10874_CR65","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1590\/S0100-879X2010005000009","volume":"43","author":"RCRd Silva","year":"2010","unstructured":"Silva RCRd, Saute JAM, Silva ACFd, Coutinho ACdO, Saraiva-Pereira M, Jardim LB (2010) Occupational therapy in spinocerebellar ataxia type 3: an open-label trial. Braz J Med Biol Res 43:537\u2013542","journal-title":"Braz J Med Biol Res"},{"key":"10874_CR66","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jnnp-2019-322168","volume":"91","author":"M Nishizawa","year":"2020","unstructured":"Nishizawa M, Onodera O, Hirakawa A, Shimizu Y, Yamada M (2020) Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials. J Neurol Neurosurg Psychiatry 91:254\u2013262","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10874_CR67","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/PL00005241","volume":"358","author":"BD Kretschmer","year":"1998","unstructured":"Kretschmer BD, Kratzer U, Schmidt WJ (1998) Riluzole, a glutamate release inhibitor, and motor behavior. Naunyn Schmiedebergs Arch Pharmacol 358:181\u2013190","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10874_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1013-9","volume":"14","author":"R de Silva","year":"2019","unstructured":"de Silva R, Greenfield J, Cook A, Bonney H, Vallortigara J, Hunt B, Giunti P (2019) Guidelines on the diagnosis and management of the progressive ataxias. Orphanet J Rare Dis 14:1\u201310","journal-title":"Orphanet J Rare Dis"},{"key":"10874_CR69","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1021\/acs.jpcb.6b02517","volume":"120","author":"C Olsson","year":"2016","unstructured":"Olsson C, Jansson HN, Swenson J (2016) The role of trehalose for the stabilization of proteins. J Phys Chem B 120:4723\u20134731","journal-title":"J Phys Chem B"},{"key":"10874_CR70","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1074\/jbc.M609532200","volume":"282","author":"S Sarkar","year":"2007","unstructured":"Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC (2007) Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and \u03b1-synuclein. J Biol Chem 282:5641\u20135652","journal-title":"J Biol Chem"},{"key":"10874_CR71","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbrc.2015.08.076","volume":"465","author":"K Tanji","year":"2015","unstructured":"Tanji K, Miki Y, Maruyama A, Mimura J, Matsumiya T, Mori F, Imaizumi T, Itoh K, Wakabayashi K (2015) Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease. Biochem Biophys Res Commun 465:746\u2013752","journal-title":"Biochem Biophys Res Commun"},{"key":"10874_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.012","volume":"27","author":"VD Felice","year":"2016","unstructured":"Felice VD, Quigley EM, Sullivan AM, O\u2019Keeffe GW, O\u2019Mahony SM (2016) Microbiota-gut-brain signalling in Parkinson\u2019s disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 27:1\u20138","journal-title":"Parkinsonism Relat Disord"},{"key":"10874_CR73","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1589\/jpts.29.1363","volume":"29","author":"P Guill\u00e9n-Rogel","year":"2017","unstructured":"Guill\u00e9n-Rogel P, San Emeterio C, Mar\u00edn PJ (2017) Associations between ankle dorsiflexion range of motion and foot and ankle strength in young adults. J Phys Ther Sci 29:1363\u20131367","journal-title":"J Phys Ther Sci"},{"key":"10874_CR74","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1139\/H07-038","volume":"32","author":"DE Warburton","year":"2007","unstructured":"Warburton DE, Bredin SS, Horita LT, Zbogar D, Scott JM, Esch BT, Rhodes RE (2007) The health benefits of interactive video game exercise. Appl Physiol Nutr Metab 32:655\u2013663","journal-title":"Appl Physiol Nutr Metab"},{"key":"10874_CR75","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/brain\/aws369","volume":"136","author":"K Reetz","year":"2013","unstructured":"Reetz K, Costa AS, Mirzazade S, Lehmann A, Juzek A, Rakowicz M, Boguslawska R, Sch\u00f6ls L, Linnemann C, Mariotti C (2013) Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain 136:905\u2013917","journal-title":"Brain"},{"key":"10874_CR76","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/mds.27676","volume":"34","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2019","unstructured":"Vel\u00e1zquez-P\u00e9rez L, Rodr\u00edguez-Diaz JC, Rodr\u00edguez-Labrada R, Medrano-Montero J, Aguilera Cruz AB, Reynaldo-Cejas L, G\u00f3ngora-Marrero M, Estupi\u00f1\u00e1n-Rodr\u00edguez A, V\u00e1zquez-Mojena Y, Torres-Vega R (2019) Neurorehabilitation improves the motor features in prodromal SCA2: a randomized, controlled trial. Mov Disord 34:1060\u20131068","journal-title":"Mov Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10874-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10874-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10874-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T18:29:18Z","timestamp":1675880958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10874-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,6]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10874"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10874-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,6]]},"assertion":[{"value":"13 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}